Atossa Therapeutics News - ATOS

Company Name	Stock Ticker Symbol	Market	Type
Atossa Therapeutics Inc	ATOS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0305	4.14%	0.7668	00:00:07

Open Price	Low Price	High Price	Close Price	Prev Close
0.74	0.72	0.7669	0.7532	0.7363

more quote information »

Recent News

Date	Time	Source	Heading
12/04/2023	08:30	GLOBE	Atossa Therapeutics Announces the Appointment of Arezoo..
11/20/2023	08:30	GLOBE	Atossa Therapeutics Announces Full Enrollment of Phase 2..
11/15/2023	17:03	EDGAR2	Form 4/A - Statement of changes in beneficial ownership of..
11/15/2023	16:15	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/15/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	09:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	09:00	EDGAR2	Form 8-K - Current report
11/13/2023	09:00	GLOBE	Atossa Therapeutics Announces Third Quarter 2023 Financial..
11/09/2023	09:00	EDGAR2	Form 8-K - Current report
11/09/2023	09:00	GLOBE	Atossa Therapeutics Appoints Financial Executive Jonathan..
10/30/2023	13:00	PRNUS	Quantum Leap Healthcare Collaborative Initiates Landmark..
10/16/2023	16:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/11/2023	08:30	PRNUS	Fast-food consumption by adolescent girls may sow the seeds..
10/06/2023	16:00	EDGAR2	Form 8-K - Current report
9/28/2023	16:28	EDGAR2	Form 8-K - Current report
9/18/2023	08:30	GLOBE	Atossa to Present at Cantor Fitzgerald Global Healthcare..
8/14/2023	08:35	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	08:30	EDGAR2	Form 8-K - Current report
8/14/2023	08:30	GLOBE	Atossa Therapeutics Announces Second Quarter 2023 Financial..
8/08/2023	09:00	GLOBE	Atossa Therapeutics to Provide Business Update and Report..
7/20/2023	09:15	GLOBE	Atossa Therapeutics Receives Approval from Health Canada to..
7/13/2023	16:20	EDGAR2	Form 8-K - Current report
7/13/2023	16:15	GLOBE	Atossa Therapeutics Regains Compliance with Nasdaq Minimum..
7/10/2023	09:15	GLOBE	Atossa Therapeutics Provides Enrollment Update for Ongoing..
7/06/2023	09:15	GLOBE	Atossa Therapeutics Announces Sponsored Research Agreement..
6/28/2023	09:15	PRNUS	Atossa Therapeutics and Quantum Leap Healthcare Provide..
6/28/2023	09:01	EDGAR2	Form 8-K - Current report
6/27/2023	09:15	GLOBE	Atossa Therapeutics Announces $10M Stock Repurchase Program
6/22/2023	16:15	GLOBE	Atossa Therapeutics Announces Sponsorship of Are You Dense..
6/21/2023	10:13	GLOBE	Atossa Therapeutics Granted Additional Patent Protection for..
6/14/2023	09:15	GLOBE	Atossa to Participate in Fireside Chat at Healthcare Virtual..
6/12/2023	09:15	GLOBE	Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort..
6/01/2023	09:10	GLOBE	Atossa Appoints Life Sciences Financial and Operations..
5/23/2023	07:00	GLOBE	Societal CDMO Enters Agreement With Atossa Therapeutics to..
5/15/2023	09:10	GLOBE	Atossa Therapeutics Announces First Quarter 2023 Financial..
5/11/2023	09:00	PRNUS	Physician-Scientist Dr. Steven Quay Provides Recommendations..
5/09/2023	09:15	GLOBE	Atossa to Present a Trial in Progress Poster on its..
4/27/2023	09:15	GLOBE	Atossa Therapeutics to Participate in Tribe Public’s Webinar..
3/22/2023	16:05	GLOBE	Atossa Therapeutics Announces Year-End 2022 Financial..
3/21/2023	13:19	PRNUS	Atossa Therapeutics and Quantum Leap Healthcare Announce New..
3/21/2023	09:15	GLOBE	Atossa Therapeutics and Quantum Leap Healthcare Announce New..
3/15/2023	09:25	GLOBE	Atossa to Present at the Sidoti Small-Cap Virtual Conference
2/23/2023	09:15	GLOBE	Atossa Doses First Patient in Phase 2 Neoadjuvant Clinical..
2/13/2023	09:15	GLOBE	Atossa Therapeutics Further Strengthens Intellectual..
1/25/2023	09:15	GLOBE	Atossa Therapeutics Issues Letter to Shareholders